Early Studies Show Remdesivir Improves COVID-19 Mortality Rates

Nurses COVID

Published

Dr. Anthony Fauci says there is clear-cut evidence that Remdesivir works. In an early clinical study, patients had a lower mortality rate when treated with Remdesivir compared to those treated with a placebo. Remdesivir was shown to decrease the average recovery rate from 15 days to 11 days.

Remdesivir can block an enzyme used by the Coronavirus and therefore blocking the effects of the virus.

This will be a new standard of care.

33 minutes ago, sevensonnets said:

We're already using it (part of the trial) and I'm quite impressed.

What are you seeing, in terms of pre and post-trial symptoms/treatment?

+ Add a Comment